We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DK icon
426
Delek US
DK
$4.35B
$390K 0.05%
+21,090
New +$378K
YETI icon
427
Yeti Holdings
YETI
$3.07B
$389K 0.05%
10,100
-7,600
-43% -$302K
UDMY
428
DELISTED
Udemy
UDMY
$387K 0.05%
+47,020
New +$379K
LIF
429
Life360
LIF
$3.54B
$386K 0.05%
+9,363
New +$412K
SYNA icon
430
Synaptics
SYNA
$3.78B
$385K 0.05%
5,046
-400
-7% -$30.3K
GNTX icon
431
Gentex
GNTX
$4.82B
$385K 0.05%
13,400
+4,200
+46% +$126K
SRAD icon
432
Sportradar
SRAD
$3.83B
$384K 0.05%
+22,143
New +$334K
DNLI icon
433
Denali Therapeutics
DNLI
$3.87B
$384K 0.05%
18,820
+10,820
+135% +$277K
WHD icon
434
Cactus
WHD
$4.76B
$383K 0.05%
6,557
-1,766
-21% -$111K
ARGX icon
435
argenx
ARGX
$65.3B
$382K 0.05%
621
+171
+38% +$100K
RSI icon
436
Rush Street Interactive
RSI
$3.03B
$379K 0.05%
27,600
-2,700
-9% -$32.8K
NOMD icon
437
Nomad Foods
NOMD
$1.69B
$377K 0.05%
22,470
+12,400
+123% +$217K
MTDR icon
438
Matador Resources
MTDR
$6.98B
$374K 0.05%
+6,651
New +$366K
ULS icon
439
UL Solutions
ULS
$15.2B
$374K 0.05%
+7,496
New +$389K
EBS icon
440
Emergent Biosolutions
EBS
$310M
$372K 0.05%
+38,901
New +$357K
RCKT icon
441
Rocket Pharmaceuticals
RCKT
$395M
$371K 0.05%
+29,536
New +$445K
SNDX icon
442
Syndax Pharmaceuticals
SNDX
$1.75B
$370K 0.05%
+28,000
New +$479K
MGRC icon
443
McGrath RentCorp
MGRC
$2.78B
$369K 0.05%
+3,300
New +$379K
ING icon
444
ING
ING
$101B
$368K 0.05%
+23,488
New +$382K
PAAS icon
445
Pan American Silver
PAAS
$22.2B
$368K 0.05%
18,200
-34,000
-65% -$761K
LYV icon
446
Live Nation Entertainment
LYV
$41.4B
$365K 0.04%
+2,821
New +$355K
WSC icon
447
WillScot Mobile Mini Holdings
WSC
$3.8B
$365K 0.04%
10,900
-7,300
-40% -$268K
SFIX
448
Stitch Fix
SFIX
$420M
$364K 0.04%
+84,538
New +$311K
CBSH icon
449
Commerce Bancshares
CBSH
$8.35B
$364K 0.04%
+6,135
New +$370K
EWBC icon
450
East-West Bancorp
EWBC
$17.8B
$364K 0.04%
+3,800
New +$373K
16 17
18
19 20

Similar funds

MCM
Mork Capital Management Healdsburg, California $156M AUM 39.85% 1-Year Est. Return
MFG
Mosaic Financial Group Chicago, Illinois $156M AUM 23.77% 1-Year Est. Return
AFW
Atlantic Family Wealth Coral Gables, Florida $156M AUM 21.68% 1-Year Est. Return
ADBIC
A.D. Beadell Investment Counsel Mequon, Wisconsin $156M AUM 29.03% 1-Year Est. Return
HSM
H Squared Management New York $156M AUM
FWM
FMA Wealth Management Duxbury, Massachusetts $156M AUM 15.22% 1-Year Est. Return
PIA
Polaris Investment Advisors Framingham, Massachusetts $156M AUM
CCP
Cyrus Capital Partners New York $156M AUM 81.61% 1-Year Est. Return

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.